PL2026779T3 - Zastosowanie kompozycji zawierającej mieszaninę hydrochinonu, acetonidu fluocynolonu oraz tretynoiny, przeznaczonej do leczenia skórnych oznak fotostarzenia - Google Patents

Zastosowanie kompozycji zawierającej mieszaninę hydrochinonu, acetonidu fluocynolonu oraz tretynoiny, przeznaczonej do leczenia skórnych oznak fotostarzenia

Info

Publication number
PL2026779T3
PL2026779T3 PL07729341T PL07729341T PL2026779T3 PL 2026779 T3 PL2026779 T3 PL 2026779T3 PL 07729341 T PL07729341 T PL 07729341T PL 07729341 T PL07729341 T PL 07729341T PL 2026779 T3 PL2026779 T3 PL 2026779T3
Authority
PL
Poland
Prior art keywords
photoaging
tretinoin
hydroquinone
mixture
intended
Prior art date
Application number
PL07729341T
Other languages
English (en)
Inventor
Doris Maria Hexsel
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of PL2026779T3 publication Critical patent/PL2026779T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07729341T 2006-05-19 2007-05-21 Zastosowanie kompozycji zawierającej mieszaninę hydrochinonu, acetonidu fluocynolonu oraz tretynoiny, przeznaczonej do leczenia skórnych oznak fotostarzenia PL2026779T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0604504A FR2901134B1 (fr) 2006-05-19 2006-05-19 Utilisation d'une composition comprenant une association d'hydroquinone, d'acetonide de fluocinolone, et de tretinoine, destinee au traitement des signes cutanes du photovieillissement
EP07729341A EP2026779B1 (fr) 2006-05-19 2007-05-21 Utilisation d'une composition comprenant une association d'hydroquinone, d'acétonide de fluocinolone, et de trétinoine, destinée au traitement des signes cutanés du photovieillissement
PCT/EP2007/054897 WO2007135132A1 (fr) 2006-05-19 2007-05-21 Utilisation d'une composition comprenant une association d'hydroquinone, d'acétonide de fluocinolone, et de trétinoine, destinée au traitement des signes cutanés du photovieillissement

Publications (1)

Publication Number Publication Date
PL2026779T3 true PL2026779T3 (pl) 2013-03-29

Family

ID=37636106

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07729341T PL2026779T3 (pl) 2006-05-19 2007-05-21 Zastosowanie kompozycji zawierającej mieszaninę hydrochinonu, acetonidu fluocynolonu oraz tretynoiny, przeznaczonej do leczenia skórnych oznak fotostarzenia

Country Status (12)

Country Link
US (1) US20090131381A1 (pl)
EP (1) EP2026779B1 (pl)
JP (1) JP5226672B2 (pl)
CA (1) CA2648946A1 (pl)
CY (1) CY1113495T1 (pl)
DK (1) DK2026779T3 (pl)
ES (1) ES2396572T3 (pl)
FR (1) FR2901134B1 (pl)
PL (1) PL2026779T3 (pl)
PT (1) PT2026779E (pl)
SI (1) SI2026779T1 (pl)
WO (1) WO2007135132A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR202013443A2 (tr) * 2020-08-26 2021-01-21 Drogsan Ilaclari Sanayi Ve Tic A S Melazma tedavi̇si̇nde kullanilan yari kati farmasöti̇k kompozi̇syonlar
WO2022172170A1 (en) 2021-02-09 2022-08-18 Universidade Do Porto Process for extraction and hemi-synthesis of pyranoanthocyanins and skincare cosmetic formulations containing them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159A (en) * 1849-03-10 Let-off motion of looms
US3856934A (en) * 1970-06-24 1974-12-24 A Kligman Skin depigmentation
US6159485A (en) * 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US7544674B2 (en) * 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition

Also Published As

Publication number Publication date
FR2901134A1 (fr) 2007-11-23
PT2026779E (pt) 2013-01-09
EP2026779B1 (fr) 2012-09-26
JP5226672B2 (ja) 2013-07-03
DK2026779T3 (da) 2013-01-21
ES2396572T3 (es) 2013-02-22
CY1113495T1 (el) 2016-06-22
JP2009537491A (ja) 2009-10-29
EP2026779A1 (fr) 2009-02-25
CA2648946A1 (fr) 2007-11-29
WO2007135132A1 (fr) 2007-11-29
SI2026779T1 (sl) 2013-02-28
FR2901134B1 (fr) 2008-10-03
US20090131381A1 (en) 2009-05-21

Similar Documents

Publication Publication Date Title
BRPI0810744A2 (pt) Moléculas absorventes de oxigênio, objetos que as contêm, e métodos de sua utilização
PL2963031T3 (pl) Proleki tetrahydrokannabinolu, kompozycje zawierające proleki tetrahydrokannabinolu i sposoby ich stosowania
EP2219600A4 (en) TOPICAL COSMETIC SKIN COMPOSITIONS AND APPLICATION METHOD THEREFOR
ZA201008839B (en) Low dose topiramate/phentermine composition and methods of use thereof
EP2125697A4 (en) POSITIVELY LOADED WATER-SOLUBLE PRODRUGS OF RETINOIDS AND RETINOIDARY COMPOUNDS WITH VERY HIGH SKIN PENETRATION RATES
BRPI0913574A2 (pt) composição de tratamento de acne compreendendo nanoprata e usos
BRPI0716592A2 (pt) Composição para cuidado da pele
SV2009003098A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
EP1998737A4 (en) BODY CARE AND DERMATOLOGICAL COMPOSITIONS
BRPI0718885A2 (pt) Composições e métodos de seu uso para melhorar a condição e aparência da pele
IL196212A (en) Preparations containing a combination of Phyto and Phytoplan that are beneficial for skin whitening
EP2126574A4 (en) MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE
BRPI0821814A2 (pt) Uso e formulação tópica de eritropoietina para a cicatrização da pele
CL2008002041A1 (es) Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad.
BRPI0812638A2 (pt) "método para diminuir a pressão em um indivíduo método para reduzir inflamação vascular em um indivíduo, composição farmacêutica para diminuira pressão sanguínea em um indivíduo e uso de uma composição"
BRPI0819931A2 (pt) Composições tópicas que compreendem aminoácidos não-proteogênicos e métodos de tratamento de pele
PL2379046T3 (pl) Miejscowe kompozycje zawierające melicope hayesii i sposób leczenia skóry
BRPI0722183A2 (pt) Composições farmacêuticas para tratar depressão e ansiedade
BRPI0820393A2 (pt) Ésteres mistos butírico-fórmico de polissacarídeos ácidos e preparação e uso dos mesmos como cosméticos para a pele.
BRPI0914084A2 (pt) composição para cuidado dos cabelos e método para prevenir o descoramento dos cabelos
BRPI0911919A2 (pt) compostos esteroidais como modificadores de melanogênese e usos dos mesmos
CL2007003561A1 (es) Uso de una composicion que contiene uno o mas agentes anticonvulsion aguda y es bioadherente a la mucosa oral y/o nasal humana para tratar convulsion aguda, convulsiones repetitivas y estado epileptico.
EP2520304A4 (en) CERAMIDE MANUFACTURER AND HUMIDIFICANT
PL2026779T3 (pl) Zastosowanie kompozycji zawierającej mieszaninę hydrochinonu, acetonidu fluocynolonu oraz tretynoiny, przeznaczonej do leczenia skórnych oznak fotostarzenia
PT1842536T (pt) Utilização de ácido alfa-cetoglutárico e 5-hidroximetilfufural para redução de stress oxidante